Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
495.60    -3.80 (-0.76%)
Bid:
495.00
Ask:
495.60
Spread: 0.60 (0.121%)
Market Cap: £1.34b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Contract Update

4 Apr 2016 07:00

RNS Number : 9826T
Chemring Group PLC
04 April 2016
 

CHEMRING GROUP PLC ("Chemring")

 

CONTRACT UPDATE

 

Chemring is pleased to announce that implementation of the 40mm ammunition contract to an end user in the Middle East, referred to in the 21 January 2016 results announcement, has commenced, with the related letter of credit in place and advance payment now having been received. Production activities at Chemring Ordnance and its supply chain partners have begun. Initial revenue will be recognised in Q2 FY16 and as previously advised, this multi-year contract is expected to provide a significant contribution to FY16.

 

-ENDS-

For further information:

 

Michael Flowers Group Chief Executive, Chemring Group PLC 01794 833901

Steve Bowers Group Finance Director, Chemring Group PLC 01794 833901

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

 

Andrew Jaques MHP Communications 020 3128 8100

John Olsen

James White

 

 

Notes to editors

 

· Chemring is a global business that specialises in the manufacture of high technology products and services to the aerospace, defence and security markets

· Employing approximately 3,000 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries worldwide

· Chemring is now organised under three strategic product segments: Countermeasures, Sensors & Electronics, and Energetic Systems

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, mission and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development, Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk

 

 

 

Cautionary statements

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

 

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSSIFLEFMSELL
Date   Source Headline
3rd Apr 20253:20 pmRNSHolding(s) in Company - Replacement
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSContract Award
1st Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20252:57 pmRNSHolding(s) in Company
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20251:46 pmRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20257:01 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20254:12 pmRNSHolding(s) in Company
27th Feb 20252:43 pmRNSDirector/PDMR Shareholdings
27th Feb 20258:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20251:29 pmRNSResult of AGM
26th Feb 20257:00 amRNSAGM Update
25th Feb 20253:50 pmRNSHolding(s) in Company
21st Feb 20252:54 pmRNSHolding(s) in Company
3rd Feb 20257:00 amRNSTotal Voting Rights
27th Jan 20253:59 pmRNSNotice of AGM
14th Jan 20257:00 amRNSRoke Contract Award
2nd Jan 202511:01 amRNSTotal Voting Rights
19th Dec 20247:00 amRNSAdditional Listing
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 20247:00 amRNSBlock listing Interim Review
17th Dec 202412:49 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSResults for the year ended 31 October 2024
5th Dec 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.